Navigation Links
Risk of CT-induced cancer minimal compared to risk of dying from disease
Date:4/30/2012

Young patients who undergo chest or abdominopelvic CT are more than 35 times more likely to die of their disease than develop a radiation induced cancer, according to an analysis of 23,359 patients, some of whom were scanned more than 15 times.

The analysis conducted at three hospitals in Boston, found that in the chest CT group, 575 out of 8,133 patients were deceased after a mean follow-up of about 4 years. "That compares to the 12 cases of radiation-induced cancer that would be expected in this group based on the BEIR-VII method, a commonly used model for determining CT-induced cancer incidence," said Rob Zondervan, one of the authors of the study.

In the abdomino-pelvic CT group, 1,124 out of 15,226 patients were deceased after a mean follow-up of about 3.5 years. "That compares to 23 cases of predicted cancer incidence," said Mr. Zondervan. "Our results indicate that the risk from underlying disease overshadows risk from CT radiation-induced malignancy, even in young adults," he said.

Records of all patients aged 18-35 who underwent a chest CT or an abdominopelvic CT from 2003-2007 were included in the analysis.

The data was broken down further based on number of CT examinations. Patients who had only one or two scans had the most predicted cases of CT-induced cancer (20 out of the 35 predicted cases). "This seeming anomaly arises from the much greater number of young adults who get one or two scans," said Mr. Zondervan. "These results do emphasize that we need to focus our radiation reduction efforts on patients who are very rarely scanned as well as those who are more frequently scanned," he said.

The analysis will be presented at the ARRS Annual Meeting May 1 in Vancouver, Canada.


'/>"/>

Contact: Samantha Schmidt
sschmidt@arrs.org
703-858-4316
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: